Glaxo, Sanofi partner on $2 billion coronavirus vaccine contract

Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a
commitment from the US federal government to pay up to $2.1 billion to help
the two companies move forward with their proposed joint coronavirus vaccine
as part of Operation Warp Speed.

[](http://rss.cnn.com/~ff/rss/cnn_topstories?a=QcvCXQ59zjQ:znz_AAgDQxE:yIl2AUoC8zA)
[](http://rss.cnn.com/~ff/rss/cnn_topstories?a=QcvCXQ59zjQ:znz_AAgDQxE:7Q72WNTAKBA)
[](http://rss.cnn.com/~ff/rss/cnn_topstories?a=QcvCXQ59zjQ:znz_AAgDQxE:V_sGLiPBpWU)
[](http://rss.cnn.com/~ff/rss/cnn_topstories?a=QcvCXQ59zjQ:znz_AAgDQxE:qj6IDK7rITs)
[](http://rss.cnn.com/~ff/rss/cnn_topstories?a=QcvCXQ59zjQ:znz_AAgDQxE:gIN9vFwOqvQ)